Technophage’s efforts to tackle COVID-19 in 2021

Technophage’s efforts to tackle COVID-19 in 2021

During this last year, Technophage has been dedicated to the development of a new biologic product for COVID-19. The company has been working together with Medinfar Group in a joint effort to make available a new biologic that will help to tackle this devastating...
Interview to Link to Leaders by Miguel Garcia, CEO of Technophage

Interview to Link to Leaders by Miguel Garcia, CEO of Technophage

In the past few months, and due to the recently initiated Phase I/IIa Clinical Trial of the bacteriophage cocktail TP-102, which has been entirely developed in the company for the treatment of diabetic foot ulcers infected by Pseudomonas aeruginosa, Acinetobacter...
Technophage featured at TV show ‘Exame Informática’

Technophage featured at TV show ‘Exame Informática’

Technophage has been recently featured in the TV show ‘Exame Informática’. In this piece, you can quickly learn a bit more about our bacteriophage cocktail TP-102, also gaining an opportunity to a virtual tour of our GMP production unit. TechnoPhage...